How growth hormone controls growth, obesity and sexual dimorphism

Trends in Genetics

Volumn 24, Issue 1, 2008, Pages 41-47

  Lichanska, Agnieszka M ^a   Waters, Michael J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; JANUS KINASE 2; SOMATOMEDIN C; STAT5B PROTEIN;

CARBOHYDRATE METABOLISM; CONTROLLED STUDY; GENE EXPRESSION; GROWTH REGULATION; HORMONAL REGULATION; HORMONE ACTION; IN VIVO STUDY; LIPID METABOLISM; LIVER; NONHUMAN; OBESITY; ONSET AGE; POSTNATAL GROWTH; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; TISSUE MICROARRAY;

ANIMALS; GROWTH HORMONE; HUMANS; LIVER; OBESITY; SEX CHARACTERISTICS; STAT5 TRANSCRIPTION FACTOR;

MUS;

EID: 37349020115     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2007.10.006     Document Type: Review

References (62)

1. Lanning N.J., and Carter-Su C. Recent advances in GH signaling. Rev. Endocrinol. Metab. Disord. 7 (2006) 225-235
2. Yakar S., et al. The role of circulating IGF-1: lessons from human and animal models. Endocrine 19 (2002) 239-248
3. Lupu F., et al. Roles of GH and IGF-1 in mouse postnatal growth. Dev. Biol. 229 (2001) 141-162
4. Udy G.B., et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 7239-7244
5. Teglund S., et al. STAT5a and STAT5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93 (1998) 841-850
6. Davey H.W., et al. STAT5b is required for GH-induced liver IGF-1 gene expression. Endocrinology 142 (2001) 3836-3841
7. Greenhalgh C.J., et al. Growth enhancement in SOCS-2 deficient mice is dependent on STAT5b. Mol. Endocrinol. 16 (2002) 1394-1406
8. Klover P., and Hennighausen L. Postnatal body growth is dependent on the transcription factors STAT5a/b in muscle: a role for autocrine/paracrine IGF-1. Endocrinology 148 (2007) 1489-1497
9. Woelfle J., et al. Acute control of IGF-1 gene transcription by GH through STAT5b. J. Biol. Chem. 278 (2003) 22696-22702
10. Woelfle J., et al. Mechanisms of GH action. Identification of conserved STAT5 binding sites that mediate GH-induced IGF-1 gene activation. J. Biol. Chem. 278 (2003) 51261-51266
11. Kofoed E.M., et al. GH insensitivity associated with STAT5b mutation. N. Engl. J. Med. 349 (2003) 1139-1147
12. Zhou Y., et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse GH receptor/binding protein gene. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 13215-13220
13. Rowland J.E., et al. In vivo analysis of GH receptor signaling domains and their associated transcripts. Mol. Cell. Biol. 25 (2005) 66-77
14. Rowland J.E., et al. Heterozygote effects in mice with partial truncations in the GH receptor cytoplasmic domain: assessment of growth parameters and phenotype. Endocrinology 146 (2005) 5278-5286
15. Nolten L.A., et al. The hepatocyte nuclear factor 3beta stimulates the transcription of the human IGF-1 gene in a direct and indirect manner. J. Biol. Chem. 271 (1996) 31846-31854
16. Neubauer H., et al. JAK2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 93 (1998) 397-409
17. Engblom D., et al. Direct glucocorticoid receptor-Stat5 interaction in hepatocytes controls body size and maturation-related gene expression. Genes Dev. 21 (2007) 1157-1162
18. Donahue L.R., and Beamer W.G. GH deficiency in "little" mice results in abberant body composition, reduced IGF-1 and IGFBP-3, but does not affect IGFBP-2, -1 or -4. J. Endocrinol. 136 (1993) 91-104
19. Takahashi J., et al. Characterization of hepatic CYP450 isozyme composition in the transgenic rat expressing low level of human GH. Xenobiotica 29 (1999) 1203-1212
20. Vidarsdottir S., et al. Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation. J. Clin. Endocrinol. Metab. 91 (2006) 3482-3485
21. Cui Y., et al. Loss of STAT5 leads to hepatosteatosis and impaired liver regeneration. Hepatology 46 (2007) 504-513
22. Corpas E., et al. Human GH and human aging. Endocr. Rev. 14 (1993) 20-39
23. Laron Z., et al. Body composition in untreated adult patients with Laron syndrome (primary GH insensitivity). Clin. Endocrinol. (Oxf.) 65 (2006) 114-117
24. Olsson B., et al. Bovine GH-transgenic mice have major alterations in hepatic expression of metabolic genes. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E504-E511
25. Stahlberg N., et al. Exploring hepatic hormone actions using a compilation of gene expression profiles. BMC Physiol. 5 (2005) 1-17
26. Flores-Morales A., et al. Microarray analysis of the in vivo effects of hypophysectomay and GH treatment on gene expression in the rat. Endocrinology 142 (2001) 3163-3176
27. Tollet-Egnell P., et al. Gene expression profile of the aging process in rat liver: normalizing effects of GH replacement. Mol. Endocrinol. 15 (2001) 308-318
28. Tollet-Egnell P., et al. GH-mediated alteration of fuel metabolism in the aged rat as determined from transcript profiles. Physiol. Genomics 16 (2004) 261-267
29. Hioki C., et al. Effects of GH on mRNA levels of uncoupling proteins 1, 2 and 3 in brown and white adipose tissues and skeletal muscle in obese mice. Horm. Res. 36 (2004) 607-613
30. Fain J.N., et al. Stimulation of lipolysis but not of leptin release by GH is abolished in adipose tissue from STAT5a and b knockout mice. Biochem. Biophys. Res. Commun. 263 (1999) 201-205
31. Clodfelter K.H., et al. Sex dependent liver gene expression is extensive and largely dependent on STAT5b: STAT5b dependent activation of male genes and repression of female genes revealed by microarray analysis. Mol. Endocrinol. 20 (2006) 1333-1351
32. Hogan J.C., and Stephens J.M. The regulation of fatty acid synthase by STAT5a. Diabetes 54 (2005) 1968-1975
33. Yin D., et al. Transcriptional regulation of fatty acid synthase gene by somatotropin in 3T3-F442A adipocytes. J. Anim. Sci. 79 (2001) 2336-2345
34. White U.A., et al. The STAT5a mediated induction of PDK4 expression by prolactin or GH in adipocytes. Diabetes 56 (2007) 1638-1646
35. Mode A., and Gustafsson J.-A. Sex and the liver-a journey through five decades. Drug Metab. Rev. 38 (2006) 197-207
36. Rinn J.L., and Snyder M. Sexual dimorphism in mammalian gene expression. Trends Genet. 21 (2005) 298-305
37. Ahluwalia A., et al. sexual dimorphism of rat liver gene expression: regulatory role of GH revealed by DNA microarray analysis. Mol. Endocrinol. 18 (2004) 747-760
38. Waxman D.J., and O'Connor C. Growth hormone regulation of sex-dependent liver gene expression. Mol. Endocrinol. 20 (2006) 2613-2629
39. Tannenbaum G.S., et al. Temporal relationship between the sexually dimorphic spontaneous GH secretory profiles and hepatic STAT5 activity. Endocrinology 142 (2001) 4595-4598
40. Park S.H., and Waxman D.J. Inhibitory cross-talk between STAT5b and liver HGNF3beta: impact on the regulation of GH pulse stimulated male-specific liver cytochrome P-450 gene expression. J. Biol. Chem. 276 (2001) 43031-43039
41. Holloway M.G., et al. Co-dependence of GH-responsive, sexually dimorphic hepatic gene expression on STAT5b and HNF4α. Mol. Endocrinol. 20 (2006) 647-660
42. Holloway M.G., et al. Loss of sexually dimorphic liver gene expression upon hepatocyte-specific deletion of Stat5a-Stat5b locus. Endocrinology 148 (2007) 1977-1988
43. Park S.H., et al. Distinctive roles of STAT5a and STAT5b in sexual dimorphism of hepatic P450 gene expression. Impact of STAT5a gene disruption. J. Biol. Chem. 274 (1999) 7421-7430
44. Laz E.V., et al. Sexual dimorphism of rat liver nuclear proteins: regulatory role of GH. Mol. Cell. Proteomics 3 (2004) 1170-1180
45. Choi H.K., and Waxman D.J. Plasma GH pulse activation of hepatic JAK-STAT5 signaling: developmental regulation and role in male-specific liver gene expression. Endocrinology 141 (2000) 3245-3255
46. Wiwi C.A., et al. Sexually dimorphic P450 gene expression in liver-specific hepatocyte nuclear factor 4alpha-deficient mice. Mol. Endocrinol. 18 (2004) 1975-1987
47. Delesque-Touchard N., et al. Synergistic action of hepatic nuclear factors 3- and 6 on CYP2C12 gene expression and suppression by GH activated STAT5b. J. Biol. Chem. 275 (2000) 34173-34182
48. Gardmo C., and Mode A. In vivo transfection of rat liver discloses NF1 and HNF6 binding sites as enhancers of GH-dependent and female-specific gene expression. J. Mol. Endocrinol. 37 (2007) 433-441
49. Vidal O.M., et al. In vivo transcript profiling and phylogenetic analysis identifies SOCS2 as a direct STAT5b target in liver. Mol. Endocrinol. 21 (2007) 293-311
50. Clarkson R.W., et al. Early responses of trans-activating factors to GH in preadipocytes: differential regulation of CCAAT enhancer-binding protein-β and C/EBPδ. Mol. Endocrinol. 9 (1994) 108-121
51. Cesena T.I., et al. Multiple mechanisms of GH-regulated gene transcription. Mol. Genet. Metab. 90 (2007) 126-133
52. Smith R.G., and Thorner M.O. Human Growth Hormone, Research and Clinical Practice (2000), Humana Press
53. Etherton T.D. Te biology of somatotropin in adipose tissue growth and nutrient partitioning. J. Nutr. 130 (2000) 2623-2625
54. Sirotkin A.V. Control of reproductive processes by growth hormone. Vet. J. 170 (2005) 307-317
55. Colao A., et al. Beginning to end: cardiovascular implications of GH deficiency and GH therapy. Growth Horm. IGF Res. 16 (2006) S41-S48
56. Waters M.J., et al. Growth hormone as a cytokine. Clin. Exp. Pharmacol. Physiol. 26 (1999) 760-764
57. Meazza C., et al. Effect of GH on the immune system. Paediatr Endocrinol Rev 1 Suppl. 3 (2004) 490-495
58. Scheepens A., et al. The role of GH in neural development. Horm. Res. 64 Suppl. 3 (2005) 66-72
59. Bartke A., and Brown-Borg H. Life extension in the dwarf mouse. Curr. Top. Dev. Biol. 63 (2004) 189-225
60. Zhang X., et al. Inhibition of estrogen-independent mammary carcinogenesis by disruption of GH signaling. Carcinogenesis 28 (2007) 143-150
61. Tollet-Egnell P., et al. Gene expression profile of the aging process in rat liver: normalizing effects of GH treatment. Mol. Endocrinol. 15 (2001) 308-318
62. Dhir R.N., and Shapiro B.H. Interpulse GH secretion in the episodic plasma profile causes the sex reversal of CYP450s in senescent male rats. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 15224-15228